![Erin Clark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erin Clark
Geen lopende functies
Profiel
Erin Clark worked as an Executive Director of Strategy Planning at Sesen Bio, Inc. in 2019.
Prior to that, Ms. Clark obtained an undergraduate degree from The Pennsylvania State University.
Eerdere bekende functies van Erin Clark
Bedrijven | Functie | Einde |
---|---|---|
CARISMA THERAPEUTICS, INC. | Investor Relations Contact | - |
Opleiding van Erin Clark
The Pennsylvania State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Sesen Bio, Inc.
![]() Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |